A phase II study evaluating the safety and efficacy of patupilone in patients with platinum refractory/resistant ovarian, primary fallopian, or peritoneal cancer Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Smit, WM
  • Sufliarsky, J
  • Werner, TL
  • Dizon, D
  • Wagnerova, M
  • Hirte, Holger
  • Delaney, R
  • Li, J
  • Weber, D
  • Schellens, JH

publication date

  • May 20, 2009